Literature DB >> 15238995

Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression.

Xiaohong Si1, Jose Javier Miguel-Hidalgo, Gillian O'Dwyer, Craig A Stockmeier, Grazyna Rajkowska.   

Abstract

The density of glial cells is reduced in certain layers of the dorsolateral prefrontal cortex in major depressive disorder (MDD). Moreover, there are reductions in the packing density of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes in the same cortical layers in younger subjects with MDD. The objective of the present study was to test if the level of GFAP is preferentially decreased in younger subjects with MDD, and whether GFAP levels are correlated with the age of onset of depression. Post-mortem brain tissue punches from dorsolateral prefrontal cortex were collected from 15 subjects with MDD and 15 age-matched psychiatrically normal control subjects. Western blots were performed on gels containing duplicated samples from both subjects of each matched pair, and on gels containing samples at different ages from either the MDD or the control group. The GFAP level was calculated as the ratio of the optical density of GFAP bands to actin bands in subjects with MDD and nonpsychiatric controls. Levels of GFAP were significantly lower in subjects with MDD as compared to controls and this decrease was most prominent in subjects less than 60 years old at the time of death. In the MDD group, GFAP levels were positively correlated with age at the time of death and show a trend toward correlation with the age of onset of depression. These findings indicate that a decrease in levels of GFAP may contribute to the pathophysiology of MDD, particularly in subjects of relatively young age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238995      PMCID: PMC3146059          DOI: 10.1038/sj.npp.1300525

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  23 in total

1.  Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

Authors:  David Cotter; Daniel Mackay; Gursh Chana; Clare Beasley; Sabine Landau; Ian P Everall
Journal:  Cereb Cortex       Date:  2002-04       Impact factor: 5.357

2.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.

Authors:  N L Johnston-Wilson; C D Sims; J P Hofmann; L Anderson; A D Shore; E F Torrey; R H Yolken
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

3.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo; J Wei; G Dilley; S D Pittman; H Y Meltzer; J C Overholser; B L Roth; C A Stockmeier
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

4.  Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression.

Authors:  M J Webster; M B Knable; N Johnston-Wilson; K Nagata; M Inagaki; R H Yolken
Journal:  Brain Behav Immun       Date:  2001-12       Impact factor: 7.217

5.  A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.

Authors:  R Damadzic; L B Bigelow; L S Krimer; D A Goldenson; R C Saunders; J E Kleinman; M M Herman
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

6.  Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium.

Authors:  M B Knable; E F Torrey; M J Webster; J J Bartko
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

7.  Distinction of early- and late-onset depression in the elderly by their lifetime symptomatology.

Authors:  R Heun; M Kockler; A Papassotiropoulos
Journal:  Int J Geriatr Psychiatry       Date:  2000-12       Impact factor: 3.485

8.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

Authors:  D Cotter; D Mackay; S Landau; R Kerwin; I Everall
Journal:  Arch Gen Psychiatry       Date:  2001-06

9.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder.

Authors:  G Rajkowska; A Halaris; L D Selemon
Journal:  Biol Psychiatry       Date:  2001-05-01       Impact factor: 13.382

10.  Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study.

Authors:  S Davis; A Thomas; R Perry; A Oakley; R N Kalaria; J T O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

View more
  82 in total

1.  Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.

Authors:  José Javier Miguel-Hidalgo; Robert Waltzer; Angela A Whittom; Mark C Austin; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2010-06-26       Impact factor: 4.839

2.  Age-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus.

Authors:  Gwendolen E Haley; Steven G Kohama; Henryk F Urbanski; Jacob Raber
Journal:  Age (Dordr)       Date:  2010-04-13

3.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  Targeting glial physiology and glutamate cycling in the treatment of depression.

Authors:  Gerald W Valentine; Gerard Sanacora
Journal:  Biochem Pharmacol       Date:  2009-04-17       Impact factor: 5.858

5.  Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides.

Authors:  Susana G Torres-Platas; Christa Hercher; Maria Antonietta Davoli; Gilles Maussion; Benoit Labonté; Gustavo Turecki; Naguib Mechawar
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

6.  Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling.

Authors:  Fang Wei; Jian Song; Cui Zhang; Jun Lin; Rong Xue; Li-Dong Shan; Shan Gong; Guo-Xing Zhang; Zheng-Hong Qin; Guang-Yin Xu; Lin-Hui Wang
Journal:  Psychopharmacology (Berl)       Date:  2019-01-03       Impact factor: 4.530

7.  Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression.

Authors:  Talaignair N Venkatraman; Ranga R Krishnan; David C Steffens; Allen W Song; Warren D Taylor
Journal:  Psychiatry Res       Date:  2009-04-30       Impact factor: 3.222

8.  Effects of kaixin jieyu decoction on behavior and glial fibrillary acidic protein expression in cerebral hippocampus of a rat vascular depression model.

Authors:  Xian-hui Zhang; Shi-jing Huang; Yan-yun Wang; Ying Zhang; Ju-hua Pan; Jun Zheng; Duo-jiao Li; Xiao-ming Lei
Journal:  Chin J Integr Med       Date:  2014-08-06       Impact factor: 1.978

9.  Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression.

Authors:  José Javier Miguel-Hidalgo; Barbara A Wilson; Syed Hussain; Ashish Meshram; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Psychiatr Res       Date:  2014-04-16       Impact factor: 4.791

10.  Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Authors:  Jose J Miguel-Hidalgo; Angela Whittom; Ashley Villarreal; Madhav Soni; Ashish Meshram; Jason C Pickett; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.